Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

DIDANOSINE

DIDANOSINE

Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview DIDANOSINE is listed in Drugs@FDA under application 077275 (ANDA).

Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength TABLET, FOR SUSPENSION;ORAL - 100MG Sponsor AUROBINDO Submission history Latest submission status date: 2012-08-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview DIDANOSINE is listed in Drugs@FDA under application 077275 (ANDA). Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength TABLET, FOR SUSPENSION;ORAL - 100MG Sponsor AUROBINDO Submission history Latest submission status date: 2012-08-14 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.